Search by Drug Name or NDC
NDC 70710-1534-06 cisatracurium besylate 10 mg/mL Details
cisatracurium besylate 10 mg/mL
cisatracurium besylate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is CISATRACURIUM BESYLATE.
Product Information
| NDC | 70710-1534 |
|---|---|
| Product ID | 70710-1534_85cccd13-2916-487a-8fd6-598c06c3cfd3 |
| Associated GPIs | 74200013102035 |
| GCN Sequence Number | 024613 |
| GCN Sequence Number Description | cisatracurium besylate VIAL 10 MG/ML INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 32770 |
| HICL Sequence Number | 010278 |
| HICL Sequence Number Description | CISATRACURIUM BESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | cisatracurium besylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cisatracurium besylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | CISATRACURIUM BESYLATE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212171 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1534-06 (70710153406)
| NDC Package Code | 70710-1534-6 |
|---|---|
| Billing NDC | 70710153406 |
| Package | 10 VIAL in 1 CARTON (70710-1534-6) / 20 mL in 1 VIAL (70710-1534-1) |
| Marketing Start Date | 2020-02-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |